Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.jcrc.2012.08.016
Title: Circuit lifespan during continuous renal replacement therapy for combined liver and kidney failure
Authors: Chua, H.-R. 
Baldwin, I.
Bailey, M.
Subramaniam, A.
Bellomo, R.
Keywords: Acute kidney injury
Acute liver failure
Bleeding risk
Circuit life
Cirrhosis
Continuous renal replacement therapy
Decompensated chronic liver disease
No anticoagulation
Thrombocytopenia
Issue Date: Dec-2012
Citation: Chua, H.-R., Baldwin, I., Bailey, M., Subramaniam, A., Bellomo, R. (2012-12). Circuit lifespan during continuous renal replacement therapy for combined liver and kidney failure. Journal of Critical Care 27 (6) : 744.e7-744.e15. ScholarBank@NUS Repository. https://doi.org/10.1016/j.jcrc.2012.08.016
Abstract: Purpose: To evaluate circuit lifespan (CL) and bleeding risk during continuous renal replacement therapy (CRRT), in combined liver and renal failure. Methods: Single-center retrospective analysis of adults with acute liver failure or decompensated cirrhosis who received CRRT, without anticoagulation or with heparinization in intensive care unit. Results: Seventy-one patients with 539 CRRT circuits were evaluated. Median overall CL was 9 (6-16) hours. CL was 12 (7-24) hours in 51 patients never anticoagulated for CRRT. In 20 patients who subsequently received heparinization, CL was 7 (5-11) hours without anticoagulation, which did not improve with systemic or regional heparinization (P = .231), despite higher peri-circuit activated partial thromboplastin time (APTT) and heparin dose. Using multivariate linear regression, patients with higher baseline APTT or serum bilirubin, or who were not mechanically ventilated, had longer CL (P < .05). Additionally, peri-circuit thrombocytopenia (P < .0001) or higher international normalized ratio (P < .05) predicted longer CL. Of 71 patients, 33 had significant bleeding events. Using multivariate logistic regression, patients with higher baseline APTT, vasoactive drug use >24 hours, or thrombocytopenia, had more bleeding complications (P < .05). Decreasing platelet counts (especially
Source Title: Journal of Critical Care
URI: http://scholarbank.nus.edu.sg/handle/10635/125370
ISSN: 08839441
DOI: 10.1016/j.jcrc.2012.08.016
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

17
checked on Jun 29, 2020

WEB OF SCIENCETM
Citations

18
checked on Jun 29, 2020

Page view(s)

39
checked on Jun 26, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.